Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2024-10-16 00:00:00 ET · period of report 2024-10-11 · accession 0001562180-24-007353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-16 | 2024-10-11 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.71 | +70.0K | 76.9K | +1,014% | +$49.7K |
| D | 2024-10-16 | 2024-10-11 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.00 | -70.0K | 127.1K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-11 | M | A | 70,000 | $0.71 | 76,904 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-10-11 | M | D | 70,000 | $0.00 | 127,122 | D | $0.71 · 2024-09-01 to 2030-09-01 | 70,000 Common Stock |